Intravascular Lithotripsy Market Size & Share, by Application Type (Coronary Artery Disease, Kidney Disorder, Facilitated Vascular Access, Peripheral Arterial Disease); End User (Hospitals, Specialty Clinics) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2036

  • Report ID: 5366
  • Published Date: Nov 03, 2023
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2023-2036

Intravascular Lithotripsy Market size is predicted to reach USD 155 billion by the end of 2036, expanding around 12% CAGR during the forecast period i.e., 2024-2036. In the year 2023, the industry size of intravascular lithotripsy was over USD 2 billion. The growth of this market can be attributed on the account of growing prevalence of cardiovascular diseases all across the globe. Cardiovascular diseases, such as coronary heart disease and peripheral artery disease, are increasing worldwide due to unhealthy lifestyles, changes in dietary habits and aging populations. This has increased the need for effective treatments and minimally invasive procedures such as angioplasty or stenting, thus raising the demand for intravascular lithotripsy. According to WHO, cardiovascular disease is the leading cause of death worldwide, with about 17.9 million deaths each year.

Furthermore, the escalating existence of complexities associated with kidney stones is the main factor driving the market expansion of intravascular lithotripsy. Besides, the growing adoption of intravascular lithotripsy in order to treat patients with coronary artery disease and constant ongoing research and development in intravascular lithotripsy further is positively influencing the market growth in the projected time frame. 

Intravascular Lithotripsy Market
Get more information on this report: Request Free Sample PDF

Intravascular Lithotripsy Sector: Growth Drivers and Challenges

Growth Drivers

  • Innovation of New Technologies - Intravascular lithotripsy technology has evolved rapidly with the introduction of new devices and catheters. The available devices are highly effective and provide better control over the delivery of negative pressure waves, thereby driving revenue growth of the intravascular lithotripsy market. Outpatient procedures are becoming increasingly popular because they are less expensive and more convenient than inpatient procedures. Intravascular lithotripsy is a minimally invasive outpatient procedure that is preferred by many patients.
  • Rise in Favorable Reimbursement Policies - Favorable reimbursement policies also drive revenue growth of the market. This has encouraged healthcare providers to offer intravascular lithotripsy as a treatment option, leading to increased demand for this procedure. In many regions, favorable reimbursement policies for intravascular lithotripsy procedures are supporting market expansion. As healthcare providers recognize the cost-effectiveness and clinical benefits of intravascular lithotripsy, reimbursement coverage is expanding. Additionally, governments around the world are increasing spending on healthcare, leading to better access to healthcare facilities and improved infrastructure. This will increase the number of intravascular lithotripsy procedures performed worldwide.
  • Growing Awareness about IVL – Increasing awareness about intravascular lithotripsy and increasing demand for techniques used in the treatment of coronary artery diseases is highly accelerating the market expansion of intravascular lithotripsy in the projected time period. Private and public organizations all across the globe are producing campaigns and initiatives that work towards raising awareness about intravascular lithotripsy among people all around the globe.


  • High in Cost and Reimbursement Issues – The initial cost of intravascular  lithotripsy along with its equipment and disposables are high in cost which is considered to be a barrier for some healthcare providers. Additionally, reimbursement policies for intravascular lithotripsy procedures vary across regions, and in some cases may not adequately cover the costs. This is anticipated to hamper the market expansion in the upcoming time period.
  • Lack of Skilled Labor is Set to Pose Restriction on the Market Growth in the Future Times
  • Technical Limitations are Expected to Restrict Market Expansion in the Forecast Time Period.

Intravascular Lithotripsy Market: Key Insights

Base Year


Forecast Year

2024 - 2036



Base Year Market Size

~USD 2 billion

Forecast Year Market Size

~USD 155 billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Intravascular Lithotripsy Segmentation

Application Type (Coronary Artery Disease, Kidney Disorder, Facilitated Vascular Access, Peripheral Arterial Disease)

Intravascular lithotripsy market from the coronary artery disease segment is set to hold the largest revenue share of 40 % by the end of 2036. Coronary heart disease is one of the most common types of cardiovascular disease and is the third leading cause of death worldwide. The high incidence of coronary heart disease has led to an increased demand for effective treatments such as intravascular lithotripsy. Intravascular lithotripsy is very effective in treating calcified plaque, a common complication of coronary artery disease. The ability of intravascular lithotripsy to safely and effectively treat calcified plaque  makes it the preferred treatment option for patients with coronary artery disease.

End User (Hospitals, Specialty Clinics)

Based on end user, the specialty clinics segment in the intravascular lithotripsy market is predicted grow substantially during the time period between 2024 – 2036. Specialty clinics focus on specific medical conditions or procedures, such as cardiovascular disease. Highly qualified medical professionals often use them. This focus allows them to provide exceptional care to patients requiring intravascular lithotripsy. Specialty clinics are often more accessible, less complicated, and more convenient for patients than hospitals. This convenience makes it easier for patients to find treatment methods, thereby contributing to the revenue growth of the specialized clinic segment in the market. Specialty clinics often have shorter wait times for appointments and procedures than hospitals, which can benefit patients who need intravascular lithotripsy. Reducing wait times can increase patient satisfaction and encourage more patients to seek care at specialty clinics. Specialty clinics typically have lower overhead costs than hospitals, which results in lower procedure costs for patients.

Our in-depth analysis of the global market includes the following segments:

                           Application Type

  • Coronary Artery Disease
  • Kidney Disorder
  •  Facilitated Vascular Access
  •  Peripheral Arterial Disease

                           End User

  • Hospitals
  • Specialty Clinics

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Intravascular Lithotripsy Industry - Regional Synopsis

North America Market Forecasts

The intravascular lithotripsy market in North America market is estimated to account for the highest CAGR of 35% by the end of 2036. North America has a favorable reimbursement policy for intravascular lithotripsy procedures, which encourages healthcare providers to offer intravenous lithotripsy as a viable treatment option. North America has a highly developed healthcare system and the region is at the forefront of rapid adoption of technological developments. Additionally, an increasing number of people suffering from kidney and cardiac disorders is also driving the growth market in this region during the estimated time period. In the United States one person in every 33 seconds loses their life to cardiac disorder.

Asia Pacific Market Statistics

The intravascular lithotripsy market in the Asia Pacific region is estimated to witness a significant market share during the time period between 2024 – 2036. The growth of this market can be primarily driven by the account of increasing awareness about intravascular lithotripsy among the people of this region along with changes in the lifestyle that results in a higher number of people suffering from chronic illness. Furthermore, rising healthcare expenditure in the region is also driving the growth of the market in the APAC region during the projected timeframe.   

Research Nester
Intravascular Lithotripsy Market size
Get more information on this report: Request Free Sample PDF

Companies Dominating the Intravascular Lithotripsy Landscape

    • Shockwave Medical Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • AVS
    • Cardiovascular Systems, Inc.
    • Abbott Laboratories
    • Siemens AG
    • Olympus America
    • Boston Scientific
    • Medispec Ltd
    • Dornier MedTech GmbH
    • Elmed Electronics & Medical Industry & Trade Inc.

In the News

  • AVS announced the closing of $8.8 million in new funding, bringing its Series B funding round to $28.8 million. The funding will continue to support clinical trials of the company's pulsed intravascular lithotripsy (PIVL) device in peripheral settings, while also advancing preclinical research to expand indications in coronary cases. In September 2022, AVS successfully enrolled, processed and collected favorable 30-day follow-up data from patients in the first-in-human POWER PAD I clinical trial. Prospective, multicenter, single-arm feasibility study evaluated the technical and clinical effectiveness of the PULSETM IVL System in the treatment of patients with femoral popliteal artery calcification.
  • Shockwave Medical, Inc. announced full commercial product availability in the United States for the Shockwave L6 peripheral IVL catheter following FDA clearance. The Shockwave L6 catheter is specifically designed to correct calcification of refractory lesions in large peripheral vessels, including the common iliac and femoral arteries. Calcification of these arteries is common and is associated with decreased procedural success and increased complications with standard intravascular techniques.

Author Credits:  Radhika Gupta, Shivam Bhutani

  • Report ID: 5366
  • Published Date: Nov 03, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The growing prevalence of cardiovascular disease and increasing research and development in intravascular lithotripsy are some of the major factors anticipated to drive the growth of the intravascular lithotripsy market.

The market is anticipated to attain a CAGR of ~12% over the forecast period, i.e., 2024-2036.

The major players in the market are of Abbott Laboratories, Siemens AG, Olympus America, Boston Scientific, Medispec Ltd, Dornier MedTech GmbH, Elmed Electronics & Medical Industry & Trade Inc., and others.

The hospital segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.

The market in North America is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.
Intravascular Lithotripsy Market Report Scope

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying